Preferred Label : Emapalumab;

NCIt synonyms : Anti-IFN gamma Monoclonal Antibody NI-0501; Anti-IFNg mAb NI-0501; Anti-interferon gamma Monoclonal Antibody NI-0501; Emapalumab-lzsg;

NCIt definition : A human monoclonal antibody against the cytokine interferon-gamma (IFN-gamma; IFNg), with potential immunomodulating activity. Upon administration, emapalumab binds to and neutralizes IFNg. This inhibits IFNg-mediated signaling pathways and suppresses the activation of the immune system. IFNg, a cell-signaling protein, plays a key role in the regulation and activation of the immune system; its upregulation is associated with certain auto-immune and auto-inflammatory diseases in which the immune system is abnormally activated.;

UNII : 3S252O2Z4X;

CAS number : 1709815-23-5; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1709815-23-5 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Gamifant;

Molecule name : NI-0501;

NCI Metathesaurus CUI : CL507913;

Codes from synonyms : 46354;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/gamifant
2021
false
false
false
Netherlands
French
English
treatment outcome
Emapalumab
antibodies, neutralizing
antibodies, monoclonal
syndication feed
summary of product characteristics
package leaflet
drug evaluation
child
adolescent
lymphohistiocytosis, hemophagocytic
familial hemophagocytic lymphocytosis
infusions, intravenous
orphan drug production
emapalumab
europe
Gamifant
Emapalumab

---
Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.